These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 11161257
1. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Barton JC, Preston BL, McDonnell SM, Rothenberg BE. Transfusion; 2001 Jan; 41(1):123-9. PubMed ID: 11161257 [Abstract] [Full Text] [Related]
2. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Hicken BL, Tucker DC, Barton JC. Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790 [Abstract] [Full Text] [Related]
4. A survey of phlebotomy among persons with hemochromatosis. McDonnell SM, Grindon AJ, Preston BL, Barton JC, Edwards CQ, Adams PC. Transfusion; 1999 Jun; 39(6):651-6. PubMed ID: 10378847 [Abstract] [Full Text] [Related]
5. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload. Barton JC, Wiener HW, Acton RT, Go RC. Blood Cells Mol Dis; 2005 Jun; 34(1):38-47. PubMed ID: 15607698 [Abstract] [Full Text] [Related]
6. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. Phatak PD, Barton JC. Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040 [Abstract] [Full Text] [Related]
7. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity. Barton JC, Barton EH, Acton RT. BMC Med Genet; 2006 Mar 13; 7():22. PubMed ID: 16533407 [Abstract] [Full Text] [Related]
8. Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis. Ünlüsoy Aksu A, Caleffi A, Pietrangelo A, Sari S, Eğritaş Gürkan Ö, Demirtaş Z, Yilmaz G, Dalgiç B. J Pediatr Hematol Oncol; 2017 Aug 13; 39(6):466-469. PubMed ID: 28067690 [Abstract] [Full Text] [Related]
9. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia. Franchini M, Gandini G, Veneri D, de Matteis G, Federici F, Solero P, Aprili G. Transfusion; 2004 Jun 13; 44(6):833-7. PubMed ID: 15157247 [Abstract] [Full Text] [Related]
10. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C. Haematologica; 2004 Oct 13; 89(10):1161-7. PubMed ID: 15477198 [Abstract] [Full Text] [Related]
11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis. Barton JC, Barton JC, Acton RT, So J, Chan S, Adams PC. Clin Gastroenterol Hepatol; 2012 Apr 13; 10(4):412-6. PubMed ID: 22265917 [Abstract] [Full Text] [Related]
12. Hemochromatosis patients as voluntary blood donors. Power TE, Adams PC. Can J Gastroenterol; 2004 Jun 13; 18(6):393-6. PubMed ID: 15190395 [Abstract] [Full Text] [Related]
13. Transfusion iron overload in adults with acute leukemia: manifestations and therapy. Barton JC, Bertoli LF. Am J Med Sci; 2000 Feb 13; 319(2):73-8. PubMed ID: 10698089 [Abstract] [Full Text] [Related]
14. Hereditary hemochromatosis: missed diagnosis or misdiagnosis? Cherfane CE, Hollenbeck RD, Go J, Brown KE. Am J Med; 2013 Nov 13; 126(11):1010-5. PubMed ID: 24054178 [Abstract] [Full Text] [Related]
15. Management of hemochromatosis. Hemochromatosis Management Working Group. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV. Ann Intern Med; 1998 Dec 01; 129(11):932-9. PubMed ID: 9867745 [Abstract] [Full Text] [Related]
16. Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes. Barton JC, Wiener HW, Acton RT, Go RC. BMC Blood Disord; 2005 Jul 25; 5():5. PubMed ID: 16042809 [Abstract] [Full Text] [Related]
17. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Casanova-Esteban P, Guiral N, Andrés E, Gonzalvo C, Mateo-Gallego R, Giraldo P, Paramo JA, Civeira F. Metabolism; 2011 Jun 25; 60(6):830-4. PubMed ID: 20846699 [Abstract] [Full Text] [Related]
18. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis. Del-Castillo-Rueda A, Moreno-Carralero MI, Cuadrado-Grande N, Alvarez-Sala-Walther LA, Enríquez-de-Salamanca R, Méndez M, Morán-Jiménez MJ. Gene; 2012 Oct 15; 508(1):15-20. PubMed ID: 22890139 [Abstract] [Full Text] [Related]
19. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. N Engl J Med; 2008 Jan 17; 358(3):221-30. PubMed ID: 18199861 [Abstract] [Full Text] [Related]
20. Hemochromatosis subjects as allogeneic blood donors: a prospective study. Leitman SF, Browning JN, Yau YY, Mason G, Klein HG, Conry-Cantilena C, Bolan CD. Transfusion; 2003 Nov 17; 43(11):1538-44. PubMed ID: 14617312 [Abstract] [Full Text] [Related] Page: [Next] [New Search]